ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0019

Single cell characterization of the circulating immune system in Sjögren’s Syndrome

Alejandro Gómez Gómez1, Héctor Corominas2, Rosario Garcia Vicuña3, Mercedes Freire González4, Sheila Melchor-Díaz5, Paloma Vela Casasempere6, Paula Estrada-Alarcón7, Jose Luis Tandaipan8, Monica Fernandez Castro9, Sara Maria Rojas Herrera10, Marina Rodríguez López11, Beatriz Paredes-Romero12, Santiago Muñoz13, Marta López14, Ignacio Braña15, Gema Bonilla16, Raúl Menor Almagro17, Sara Manrique-Arija18, Mª Angeles Blazquez Cañamero19, Lilian López-Núñez20, Carles Galisteo Veiga21, Juan José Alegre-Sancho22, Jose Rosas Gómez de Salazar23, Jose Javier Pérez Venegas24, Judit Font-Urgelles25, José Andrés Román Ivorra26, José Miguel Sequí-Sabater27, Rafaela Ortega-Castro28, Clara Moriano29, Guadalupe Manzano-Canabal30, Cilia Peralta-Ginés31, Javier Narváez32, Rafael Cáliz-Cáliz33, Javier Martínez-Ferrin34, Lara Sánchez Bilbao35, Belén Serrano-Benavente36, Natalia Boix- Martí37, Ares Selles-Rius38, Maribel Pérez39, Juan Cañete40, Núria Palau Balaña38, Damiana Alvarez Errico39, Yolanda Guillén41, Juan Ángel Patiño Galindo41, Antonio Julià1, Sara Marsal Barril42 and Jose Luis Andreu43, 1Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Barcelona, Spain, 2Hospital de la Santa Creu i Sant Pau, Rheumatology, Barcelona, Barcelona, Spain, 3Hospital Universitario de la Princesa, Madrid, Spain, 44 Hospital Universitario A Coruña, Rheumatology, A Coruña, La coruna, Spain, 5Hospital Universitario 12 de Octubre, Rheumatology, Madrid, Madrid, 6Hospital General Universitario Alicante, Alicante, Comunidad Valenciana, Spain, 7Hospital de San Juan Despí Moisès Broggi, Barcelona, Spain, 8Rheumatology. Hospital Universitario de la Santa Creu i Sant Pau, Barcelona, Spain, 9PUERTA DE HIERRO HOSPITAL, Madrid, Spain, 10Hospital de Mérida, Rheumatology, Badajoz, Badajoz, Spain, 11Complejo Hospitalario Universitario de Santiago, Rheumatology, Santiago de Compostela., Santiago de Compostela, Spain, 12Hospital Universitario Infanta Sofía;Universidad Europea de Madrid. Faculty of Medicine, Health and Sports. Department of Medicine; FIIB HUIS-HUHEN, San Sebastian de los Reyes, Spain, 13Hospital Universitario Infanta Sofía;Universidad Europea de Madrid. Faculty of Medicine, Health and Sports. Department of Medicine; FIIB HUIS-HUHEN, Madrid, Spain, 14Complex Hospitalari Universitari Moisés Broggi, Barcelona, Spain, 15Hospital Universitario Central de Asturias, Oviedo, Spain, 16Hospital Universitario La Paz, Rheumatology, Madrid, Madrid, Spain, 17Department of Rheumatology, Hospital de Jerez, Spain, Puerto De Santa María, Spain, 18Hospital Regional Universitario Málaga, Malaga, Spain, 19Hospital Ramon y Cajal, Madrid, Spain, 20Hospital Son Llatzer, Rheumatology, Palma de Mallorca, Palma de Mallorca, Spain, 21Hospital Parc Taulí, Rheumatology, Sabadell, Sabadell, Spain, 22Hospital Universitario Doctor Peset, Valencia, Spain, 23Hospital Marina Baixa, PALMA DE MALLORCA, Spain, 24Virgen Macarena University Hospital, Sevilla, Spain, Sevilla, Spain, 25Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 26Hospital Universitari i Politècnic La Fe, Valencia, Spain, 27Hospital Universitario La Fe (Valencia), Valencia, Spain, 28Rheumatology service/Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/ Reina Sofia University Hospital/ University of Cordoba, Spain, Cordoba, Andalucia, Spain, 29Hospital León, LEON, Castilla y Leon, Spain, 30Hospital Virgen de la Concha (Zamora), Zamora, Spain, 31Hospital Clínico Universitario Lozano Blesa, Zaragoza, Spain, 32Hospital Universitario de Bellvitge, Barcelona, Spain, 33Hospital Universitario Virgen de las Nieves, Rheumatology, Granada, Granada, Spain, 34Hospital Universitario Virgen de la Arrixaca, Rheumatology, Murcia, Murcia, Spain, 35Rheumatology Division, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain, 36Hospital Gregorio Marañon, Madrid, Spain, 37Hospital Univetsitari Vall d'Hebron, Rheumatology Department, Barcelona, Spain, 38Rheumatology Research Group, Vall d'Hebron University Hospital, Barcelona, Spain, 39IMIDomics, Barcelona, Barcelona, Spain, 40Rheumatology Department, Hospital Clínic and IDIBAPS, Barcelona, Spain, Barcelona, Spain, 41IMIDomics, Barcelona, Spain, 42Vall Hebron Hospital Research Institute, Barcelona, Spain, 43Hospital Universitario Puerta de Hierro, Majadahonda, Spain

Meeting: ACR Convergence 2025

Keywords: Bioinformatics, immunology, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0019–0048) Genetics, Genomics & Proteomics Poster

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Sjögren’s syndrome (SS) is a chronic autoimmune disease characterized by the infiltration of circulating immune cells into the salivary and lacrimal glands. The properties of the peripheral immune cells associated to SS are only partially understood. In this work we aimed to comprehensively characterize the compositional cell changes and the gene expression changes of the circulating immune system associated to Sjögren’s Syndrome.

Methods: Peripheral Blood Mononuclear Cells were collected from 32 SS patients and 10 sex and age matched healthy controls. Single cell transcriptome analysis was performed using droplet-based 3’ scRNA-Seq technology. After clustering and annotation of the main circulating innate and adaptive immune cell types, compositional differences were tested using the cell frequencies using linear modelling. Alternatively, we used Covariant Neighborhood Analyses to identify compositional changes associated to diseases and not captured by the standard cell clusters. For each cell type, differential gene expression was performed using MAST.

Results: A total of 198,078 peripheral blood cells passed the quality control and were clustered and annotated into 27 immune cell types. SS was associated with an increased abundance of cells from the T compartment, including CD4+TH2, CD8+TEM and proliferative T. Conversely, SS had significantly less circulating CD4 and CD8+ naive T cells, MAIT, pDC, DC3 and memory B cells compared to healthy controls. CNA analysis identified an independent subpopulation of CD8+ T cells significantly expanded in SS. Differential gene expression analyses revealed transcriptomic changes in all cell compartments, with more significant regulation occurring in specific cell types including NKCD16+, Tregs, TFH, B memory, and CD14+CCL2Hi monocytes. Pathway analysis identified a strong interferon-response signature across many cell types as well as cell-specific aberrant regulatory changes. The CD8+ T cell subpopulation associated to SS through CNA showed a significant enrichment of genes associated to SS risk.

Conclusion: This study provides the largest single cell transcriptomic analysis of circulating immune cells in SS performed to date. The changes both at the compositional and gene expression levels provide a comprehensive characterization of the immunological processes that are altered in the disease.


Disclosures: A. Gómez Gómez: None; H. Corominas: None; R. Garcia Vicuña: None; M. Freire González: None; S. Melchor-Díaz: None; P. Vela Casasempere: None; P. Estrada-Alarcón: None; J. Tandaipan: None; M. Fernandez Castro: None; S. Rojas Herrera: None; M. Rodríguez López: None; B. Paredes-Romero: None; S. Muñoz: Janssen, 1, 2, 5, 6, 7; M. López: None; I. Braña: None; G. Bonilla: None; R. Menor Almagro: None; S. Manrique-Arija: None; M. Blazquez Cañamero: Astrazeneca, 12, conference registrations, Gsk, 6, Novartis, 12, conference registrations, Rubio, 12, conference registrations; L. López-Núñez: None; C. Galisteo Veiga: None; J. Alegre-Sancho: None; J. Rosas Gómez de Salazar: None; J. Pérez Venegas: AstraZeneca, 6, Janssen, 4, 6, UCB, 6; J. Font-Urgelles: None; J. Andrés Román Ivorra: AstraZeneca, 6, GSK, 6, UCB, 6; J. Sequí-Sabater: None; R. Ortega-Castro: None; C. Moriano: None; G. Manzano-Canabal: None; C. Peralta-Ginés: None; J. Narváez: None; R. Cáliz-Cáliz: None; J. Martínez-Ferrin: None; L. Sánchez Bilbao: AbbVie/Abbott, 6, Eli Lilly, 6, Janssen, 6, UCB, 6; B. Serrano-Benavente: None; N. Boix- Martí: None; A. Selles-Rius: None; M. Pérez: None; J. Cañete: None; N. Palau Balaña: None; D. Alvarez Errico: None; Y. Guillén: None; J. Patiño Galindo: None; A. Julià: None; S. Marsal Barril: None; J. Andreu: None.

To cite this abstract in AMA style:

Gómez Gómez A, Corominas H, Garcia Vicuña R, Freire González M, Melchor-Díaz S, Vela Casasempere P, Estrada-Alarcón P, Tandaipan J, Fernandez Castro M, Rojas Herrera S, Rodríguez López M, Paredes-Romero B, Muñoz S, López M, Braña I, Bonilla G, Menor Almagro R, Manrique-Arija S, Blazquez Cañamero M, López-Núñez L, Galisteo Veiga C, Alegre-Sancho J, Rosas Gómez de Salazar J, Pérez Venegas J, Font-Urgelles J, Andrés Román Ivorra J, Sequí-Sabater J, Ortega-Castro R, Moriano C, Manzano-Canabal G, Peralta-Ginés C, Narváez J, Cáliz-Cáliz R, Martínez-Ferrin J, Sánchez Bilbao L, Serrano-Benavente B, Boix- Martí N, Selles-Rius A, Pérez M, Cañete J, Palau Balaña N, Alvarez Errico D, Guillén Y, Patiño Galindo J, Julià A, Marsal Barril S, Andreu J. Single cell characterization of the circulating immune system in Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/single-cell-characterization-of-the-circulating-immune-system-in-sjogrens-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/single-cell-characterization-of-the-circulating-immune-system-in-sjogrens-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology